Merck | MRK - Operating Expenses

Stock Price
107.70
Daily Change
-0.10 -0.09%
Monthly
-14.66%
Yearly
-20.84%
Q1 Forecast
104.71

Merck reported EUR4.78B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Adidas EUR 5.91B 18M Dec/2025
Adyen EUR 766.45M 83.9M Jun/2025
Akzo Nobel EUR 2.16B 95M Dec/2025
Alcon AG USD 2.41B 123M Dec/2025
Amadeus IT EUR 1.28B 129M Dec/2025
Amarin USD 51.37M 14.6M Sep/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
BASF EUR 14.21B 372M Dec/2025
Bayer EUR 10.33B 126M Dec/2025
Beiersdorf EUR 4.16B 212M Dec/2025
Covestro EUR 3.24B 5.46B Dec/2025
Danone EUR 11.92B 131M Jun/2025
Fresenius EUR 5.25B 337M Dec/2025
Fresenius Medical Care EUR 4.41B 27.91M Dec/2025
Galapagos EUR 120.26M 7.43M Dec/2025
Genmab DKK 565M 38M Jun/2025
Givaudan CHF 1.5B 1.35B Jun/2024
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
GRIFOLS EUR 1.71B 193M Dec/2025
Henkel EUR 8.67B 122M Dec/2025
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Infineon EUR 3.27B 131M Dec/2025
Linde USD 6.21B 52M Sep/2025
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.78B 669M Dec/2025
Novartis USD 9.86B 115M Sep/2025
Philips EUR 4.38B 405M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
UCB EUR 2.36B 108M Dec/2024